Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus

Immunity

Volumn 15, Issue 3, 2001, Pages 435-443

  Rozzo, Stephen J ^a   Allard, John D ^b   Choubey, Divaker ^c   Vyse, Timothy J ^a   Izui, Shozo ^d   Peltz, Gary ^b   Kotzin, Brian L ^a,e  

^a UNIVERSITY OF COLORADO   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^e NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA; INTERFERON; PROTEIN; PROTEIN IF1202; PROTEIN IF1203; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONGENIC STRAIN; CONTROLLED STUDY; CROSS BREEDING; DISEASE PREDISPOSITION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE SEQUENCE; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; SEQUENCE ANALYSIS; SPLEEN CELL; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 0034814052     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00196-0     Document Type: Article

References (43)

1. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis
2. p202: An interferon-inducible negative regulator of cell growth
3. Inhibition of E2F-4/DP-1-stimulated transcription by p202
4. Interferon action: Cytoplasmic and nuclear localization of the interferon-inducible 52-kDa protein that is encoded by the Ifi202 gene from the gene 200 cluster
5. Binding of an interferon-inducible protein (p202) to the retinoblastoma protein
6. Inhibition of E2F-mediated transcription by p202
7. Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1
8. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition
9. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner
10. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression
11. Single-tube genotyping without oligonucleotide probes
12. Self-tolerance checkpoints in B lymphocyte development
13. In vitro and in vivo expression analysis of the interferon-inducible 203 gene
14. Interferons as gene activators. Characteristics of an interferon-activatable enhancer
15. Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1)
16. The genetics of human systemic lupus erythematosus
17. Transcription and growth regulatory functions of the HIN-200 family of proteins
18. Identification of Complement factor 5 (C5) as a susceptibility locus for experimental allergic asthma
19. Lupus susceptibility loci in New Zealand mice
20. Systemic lupus erythematosus
21. p202 prevents apoptosis in murine AKR-2B fibroblasts
22. Resting B cells from New Zealand Black mice demonstrate a defect in apoptosis induction following surface IgM ligation
23. The Ifi 200 genes: An emerging family of IFN-inducible genes
24. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc
25. The interferon-inducible p202 protein as a modulator of transcription: Inhibition of NF-kappa B, c-Fos, and c-Jun activities
26. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes
27. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes
28. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains
29. Polygenic control of susceptibility to murine systemic lupus erythematosus
30. Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis
31. Enhanced susceptibility to lupus contributed from the nonautoimmune C57BL/10, but not C57BL/6, genome
32. Interferons as gene activators. Cloning of the 5′ terminus and the control segment of an interferon activated gene
33. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity
34. The genes of systemic autoimmunity
35. Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus
36. Genetic susceptibility to systemic lupus erythematosus
37. Control of multiple autoantibodies linked with a lupus nephritis susceptibility locus in New Zealand black mice
38. Contributions of Ea(z) and Eb(z) MHC genes to lupus susceptibility in New Zealand mice
39. Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus
40. Genetic dissection of systemic lupus erythematosus
41. Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster
42. The interferon- and differentiation-inducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max